NEW YORK, March 11, 2024 /PRNewswire/ — The global amyotrophic lateral sclerosis (ALS) treatment market size is estimated to grow by USD 663.7 million at a CAGR of 12.79% between 2023 and 2028. North America is poised to contribute 42% to the global market growth. The US, hosting major…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.